Resolution: standard / high
Figure 5.
Antitumor activity against murine colon carcinoma CT26 in Balb/C mice following administration of TGIK.
Hill et al. Journal of Immune Based Therapies and Vaccines 2005 3:5 doi:10.1186/1476-8518-3-5
Download authors' original image